Gene: RECQL
Official Full Name: RecQ like helicaseprovided by HGNC
Gene Summary: The protein encoded by this gene is a member of the RecQ DNA helicase family. DNA helicases are enzymes involved in various types of DNA repair, including mismatch repair, nucleotide excision repair and direct repair. The encoded protein is involved in the processing of Holliday junctions, the suppression of sister chromatid exchanges, telomere maintenance, and is required for genotoxic stress resistance. Defects in this gene have been associated with several types of cancer. [provided by RefSeq, Jan 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02251 | RECQL Knockout cell line (HeLa) | Human | RECQL | 1:3~1:6 | Negative | Online Inquiry |
KO02252 | RECQL Knockout cell line (HCT 116) | Human | RECQL | 1:2~1:4 | Negative | Online Inquiry |
KO02253 | RECQL Knockout cell line (HEK293) | Human | RECQL | 1:3~1:6 | Negative | Online Inquiry |
KO02254 | RECQL Knockout cell line (A549) | Human | RECQL | 1:3~1:4 | Negative | Online Inquiry |
RECQL Gene Knockout Cell Lines are specialized mammalian cell lines engineered to lack the RECQL gene, which encodes a crucial helicase involved in maintaining genome stability. These cell lines serve as powerful tools for studying the multifaceted roles of the RECQL protein in DNA repair, replication, and cellular response to genomic stress. By utilizing CRISPR/Cas9 technology, these knockout cell lines allow researchers to analyze the impact of RECQL deficiency on various cellular pathways and phenomena, including cancer progression, aging, and the mechanisms of hereditary disorders.
The primary function of RECQL is to unwind DNA during replication and repair processes, thereby preventing the accumulation of DNA damage that can lead to genomic instability and tumorigenesis. In the absence of RECQL, cells exhibit increased sensitivity to DNA-damaging agents and abnormal cell cycle progression, making these knockout lines invaluable for exploring therapeutic strategies targeting DNA repair mechanisms. Researchers can investigate the differential effects of mutations that surface in RECQL-deficient environments, facilitating discoveries that could inform novel cancer treatments.
Compared to conventional cell lines, RECQL Gene Knockout Cell Lines provide a unique advantage by offering direct insight into the specific contributions of the RECQL gene in vivo. This specificity enhances the reliability of experimental results and broadens the horizon for translational applications, particularly in oncology and genetic research. Additionally, their robust performance in a variety of assays makes them ideal for both academic and clinical investigations.
For researchers and clinicians focused on cancer biology, genetics, or pharmaceutical development, the value of these cell lines lies in their ability to streamline experimental approaches and uncover insights that may lead to breakthroughs in understanding human disease. Our company prides itself on delivering high-quality biological products substantiated by rigorous validation processes and our team’s extensive expertise in cell line technology. By choosing RECQL Gene Knockout Cell Lines, you are investing in a product that empowers innovation and advancement in life science research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.